[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Quality Compounders to Own for Decades

3 Quality Compounders to Own for Decades

FIX : 1,697.84 (+11.70%)
LLY : 1,154.97 (-4.55%)
DASH : 197.53 (+2.07%)
3 Divine Dividend-Growth ETFs

If you want to diversify your holdings across many dividend growers all at once, check out these dividend-growth ETFs.

MSFT : 451.10 (+15.51%)
LIN : 508.64 (-0.49%)
AVGO : 387.84 (+4.73%)
EFAD : 44.26 (+1.03%)
VIG : 240.06 (+0.63%)
XOM : 156.97 (+0.14%)
LLY : 1,154.97 (-4.55%)
WMT : 111.10 (-2.73%)
NOBL : 57.19 (-1.75%)
ED : 109.66 (-2.31%)
ASML : 1,651.44 (+6.50%)
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C

In TRIUMPH-2, adults with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost up to an average of 49.6 lbs (20.8%) at 80 weeks

LLY : 1,154.97 (-4.55%)
Lilly confirms date and conference call for second-quarter 2026 financial results announcement

INDIANAPOLIS , July 22, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2026 financial results on August 5, 2026. Lilly will also conduct a conference call...

LLY : 1,154.97 (-4.55%)
Insider Moves Are Sending Mixed Signals Across the Tech Sector

Broadcom sees insider selling after volatile 2026 trading, while Netskope draws heavy insider buying post-earnings drop and Eli Lilly CEO David Ricks purchases Adobe shares.

AVGO : 387.84 (+4.73%)
ADBE : 247.90 (-5.90%)
LLY : 1,154.97 (-4.55%)
NTSK : 12.10 (+1.17%)
What You Need to Know Ahead of Eli Lilly's Earnings Release

Eli Lilly will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

XLV : 163.52 (-1.64%)
$SPX : 7,437.63 (+1.66%)
LLY : 1,154.97 (-4.55%)
Novo Nordisk Sues Eli Lilly Over Obesity Drug Advertising Claims

Novo Nordisk ($NVO) filed a lawsuit against Eli Lilly ($LLY), alleging Lilly's advertising for Zepbound and Mounjaro relies on outdated clinical comparisons that understate the performance of Novo's latest...

NVO : 51.61 (+0.06%)
LLY : 1,154.97 (-4.55%)
How AI-Driven Protein Generation Is a Margin Killer for Drugmakers

The next tech revolution in biotech might save lives, but it could also crush pharmaceutical margins.

GOOGL : 333.66 (-0.91%)
LLY : 1,154.97 (-4.55%)
NVS : 158.44 (-0.25%)
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END

HELP : 8.14 (+2.91%)
CMPS : 11.57 (+6.15%)
ATAI : 7.18 (unch)
JNJ : 255.82 (-3.66%)
LLY : 1,154.97 (-4.55%)
Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?

Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?

LLY : 1,154.97 (-4.55%)

Barchart Exclusives

Here’s Why Verizon Stock Is a Buy for Income Investors in August
A safer dividend, stronger free cash flow, and new growth opportunities make Verizon increasingly attractive for income-focused investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.